which glp 1 agonists have cardiovascular benefit The effects of GLP-1 receptor beyond obesity and type 2 diabetes: An anti-atherosclerotic action GLP-1 Muscle Loss Explained |

Questions remain about the safety of these drugs with regard to the risk of pancreatitis and the development of MTC in patients receiving liraglutide

In the coming weeks, Novo Nordisk is expected to release fresh Phase III data for its next-generation weight loss treatment CagriSema, which analysts say could be the next big thing in the obesity space

as the science nerd that I am

The decision to adjust dose based on heart rate should involve the overall clinical picture, not just one number in isolation

The fiber in leafy greens and broccoli not only supports digestion but also helps alleviate constipation, a common side effect of GLP-1 medications

Al-Karadsheh, T